It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-030.mrc:42952700:3501
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-030.mrc:42952700:3501?format=raw

LEADER: 03501cam a2200685 i 4500
001 14634204
005 20220625225826.0
006 m o d
007 cr |n|||||||||
008 190423t20202020mou obf 000 0 eng d
035 $a(OCoLC)on1098179821
035 $a(NNC)14634204
040 $aMMU$beng$erda$epn$cMMU$dOCLCO$dCOU$dTMC$dCASUM$dOCLCO$dUAB$dOCLCO$dUIU$dN$T$dYDX$dOCLCA$dOCLCQ$dOCLCO$dOCLCA$dOCLCQ$dOCLCO
020 $a0323674879$q(electronic book)
020 $a9780323674874$q(electronic bk.)
020 $z9780323661386$q(paperback)
020 $z0323661386$q(paperback)
035 $a(OCoLC)1098179821
050 4 $aRM170$b.G33 2020
060 4 $aWB 354$bG136i 2020
082 04 $a615.6
049 $aZCUA
100 1 $aGahart, Betty L.,$eauthor.
245 10 $aGahart's 2020 intravenous medications :$ba handbook for nurses and health professionals /$cBetty L. Gahart, Adrienne R. Nazareno, Meghan Q. Ortega.
246 30 $a2020 intravenous medications
250 $aThirty-sixth edition.
264 1 $aSt. Louis, Mo. :$bElsevier,$c[2020]
264 4 $c©2020
300 $a1 online resource (xxii, 1409 pages)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
500 $aRevised edition of: Gahart's 2019 intravenous medications : a handbook for nurses and health professionals / Betty L. Gahart, Adrienne R. Nazareno, Meghan Q. Ortega. Thirty-fifth edition. [2019]
504 $aIncludes bibliographical references (page xxii).
505 0 $aGeneral dilution charts (inside front cover and facing page) -- How to use this book -- Preface -- Format and content of intravenous medications -- Key to abbreviations -- Important IV therapy facts -- Resources -- IV drugs [alphabetical drug monographs] -- Appendices. Recommendations for the safe use and handling of cytotoxic drugs -- FDA pregnancy categories -- U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute Common terminology criteria for adverse events -- Information for patients receiving immunosuppressive agents -- Recently approved drugs
588 0 $aOnline resource; title from electronic title page (ClinicalKey, April 23, 2019).
650 0 $aIntravenous therapy$vHandbooks, manuals, etc.
650 0 $aNursing$vHandbooks, manuals, etc.
650 0 $aIntravenous therapy.
650 0 $aInjections, Intravenous.
650 12 $aInfusions, Intravenous
650 12 $aInjections, Intravenous
650 6 $aThérapeutique intraveineuse$vGuides, manuels, etc.
650 6 $aThérapeutique intraveineuse.
650 6 $aInjections intraveineuses.
650 7 $aIntravenous therapy.$2fast$0(OCoLC)fst00977816
650 7 $aNursing.$2fast$0(OCoLC)fst01041731
655 2 $aHandbook
655 2 $aNurses Instruction
655 4 $aElectronic books.
655 7 $ahandbooks.$2aat
655 7 $amanuals (instructional materials)$2aat
655 7 $aHandbooks and manuals.$2fast$0(OCoLC)fst01423877
655 7 $aHandbooks and manuals.$2lcgft
655 7 $aGuides et manuels.$2rvmgf
700 1 $aNazareno, Adrienne R.,$eauthor.
700 1 $aOrtega, Meghan Q.,$eauthor.
776 08 $iPrint version:$aGahart, Betty L.$tGahart's 2020 intravenous medications.$dSt. Louis, Mo. : Elsevier, [2020]$z9780323661386$w(OCoLC)1055686273
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio14634204$zAll EBSCO eBooks
852 8 $blweb$hEBOOKS